Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas
Phase 1 Unknown
100 enrolled
Patriot
Phase 1 Unknown
87 enrolled
OUTREACH
Phase 1 Unknown
75 enrolled
A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults with Non-Small Cell Lung Cancer
Phase 1 Unknown
24 enrolled
Clinical Trial of HG146 Administered to Subjects with Advanced Solid Tumors or Lymphoma
Phase 1 Unknown
96 enrolled
A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination with Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors
Phase 1 Unknown
140 enrolled
Trimelvax001
Phase 1 Unknown
20 enrolled
A Phase 1 Study of BST02 in Treating Locally Advanced Liver Cancer
Phase 1 Unknown
9 enrolled
AMT-562 in Patients With Selected Advanced Solid Tumors
Phase 1 Unknown
72 enrolled
GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results
Phase 1 Unknown
68 enrolled
Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS
Phase 1 Unknown
24 enrolled
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Phase 1 Unknown
77 enrolled
U87 CART in Treatment of Advanced Solid Tumor
Phase 1 Unknown
12 enrolled
A Phase Ib/â…¡ Study of NTQ1062 in Combination With Fulvestrant in Patients With Advanced HR Positive /HER-2 Negative Breast Cancer
Phase 1 Unknown
42 enrolled
A Phase I Study to Investigate the Safety, Tolerability and PK of HLX60 (Anti-GARP Monoclonal Antibody) in Subjects With Solid Tumors or Lymphoma
Phase 1 Unknown
11 enrolled
Tumor Nutritional Therapy in the First-line Treatment of Stage IV NSCLC
Phase 1 Unknown
120 enrolled
CHANCES
Phase 1 Unknown
27 enrolled
A Clinical Trial of TQB2934 for Injection in Multiple Myeloma Subjects
Phase 1 Unknown
140 enrolled
A Clinical Study of MIL93 in Solid Tumors.
Phase 1 Unknown
228 enrolled
Safety/Tolerability, PK and Efficacy of IMB071703 Injection in Patients With Advanced Solid Tumors
Phase 1 Unknown
93 enrolled
A Clinical Study of T3011 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer
Phase 1 Unknown
8 enrolled
A Phase I Study to Assess PSMA+ and PSMA- Tumour Lesions
Phase 1 Unknown
5 enrolled
PITHAC
Phase 1 Unknown
39 enrolled
Evaluate CART-BCMA in Patients With Relapsed and/or Refractory Multiple Myeloma
Phase 1 Unknown
15 enrolled
The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the Recurrent Glioblastoma
Phase 1 Unknown
16 enrolled
Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent
Phase 1 Unknown
30 enrolled
F01 in the Treatment of Relapsed/Refractory Non-hodgkin's Lymphoma
Phase 1 Unknown
55 enrolled
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SKI-G-801 in Patients With Advanced Solid Tumors
Phase 1 Unknown
36 enrolled
RVU120 in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome
Phase 1 Unknown
112 enrolled
The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1
Phase 1 Unknown
10 enrolled
IMC001 for Clinical Research on Advanced Digestive System Malignancies
Phase 1 Unknown
48 enrolled
NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer
Phase 1 Unknown
38 enrolled
PBF-1129 in Patients With NSCLC
Phase 1 Unknown
18 enrolled
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
Phase 1 Unknown
42 enrolled
A Study of ICP-033 in Patients With Advanced Solid Tumors
Phase 1 Unknown
60 enrolled
Clinical Study on the Treatment of Advanced Recurrent Tumors With Anticancer Mouse Characteristic Human Neutrophils
Phase 1 Unknown
18 enrolled
A Phase I Study of SY-4835 in Patients With Advanced Solid Tumors
Phase 1 Unknown
40 enrolled
A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML
Phase 1 Unknown
198 enrolled
A Study of BH009 in Head and Neck Squamous Cell Carcinoma and Ovarian Cancer
Phase 1 Unknown
24 enrolled
ERK Inhibitor JSI-1187 in Advanced Solid Tumors
Phase 1 Unknown
60 enrolled
Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376
Phase 1 Unknown
75 enrolled
JIVAN
Phase 1 Unknown
30 enrolled
Evaluate Safety, Tolerability, PK, Preliminary Clinical Activity of OB318 in Patients With Advanced Solid Malignancies
Phase 1 Unknown
30 enrolled
Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma
Phase 1 Unknown
34 enrolled
A Phase Ia Clinical Study of QLF31907 Injection in Patients With Advanced Malignant Tumors
Phase 1 Unknown
54 enrolled
A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer.
Phase 1 Unknown
75 enrolled
A Study Comparing Pharmacokinetic and Safety of QL2107 and Keytruda® (Marketed in China and the United States) in Healthy Adults
Phase 1 Unknown
168 enrolled
Longitudinal Immune-phenotyping of HCC Following MK-3475
Phase 1 Unknown
8 enrolled
Open Label Clinical Trial of Intravenous Crotoxin Part 3
Phase 1 Unknown
24 enrolled
INS19 CAR-T Cells for the Treatment of Relapsed or Refractory Acute B Lymphoblastic Leukemia
Phase 1 Unknown
12 enrolled